Overview
- 8 inspections across 8 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-10-22.
At a glance
Inspections
8
Sites
8
Observations
2
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Michael L. Schilsky, M.D. | 22 Oct 2021 | Human Drugs | |
| Andrea J. Bullock, MD | 6 Oct 2021 | Medical Devices & Rad Health | View 483 → |
| Thomas D. Cha, MD | 9 Sep 2021 | Medical Devices & Rad Health | |
| Hanny Al-Samkari, MD | 27 Aug 2021 | Human Drugs | |
| Akebia Therapeutics, Inc. | 12 Aug 2021 | Human Drugs |
Sites inspected
Michael L. Schilsky, M.D.New Haven, United States1 insp.
Andrea J. Bullock, MDBoston, United States1 insp.
Thomas D. Cha, MDBoston, United States1 insp.
Hanny Al-Samkari, MDBoston, United States1 insp.
Akebia Therapeutics, Inc.Cambridge, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Matthew C Watson4 shared
Victoria M Daddeo1 shared
Michael Serrano1 shared
Yvette M Lacour-Davis1 shared
Full investigator report
Get the verbatim findings behind Alicia A Dalley's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site